Circulating tumour cells and cell-free DNA as tools for managing breast cancer. - Wikidata - wikimedia - TriplyDB

Circulating tumour cells and cell-free DNA as tools for managing breast cancer.

Circulating tumour cells and cell-free DNA as tools for managing breast cancer.

http://www.wikidata.org/entity/Q38109808

about

Cell-free circulating tumor DNA in cancer cfDNA analysis from blood in melanoma Molecular Imaging of Biomarkers in Breast Cancer Revealing the Complexity of Breast Cancer by Next Generation Sequencing Epigenetic mechanisms involved in melanoma pathogenesis and chemoresistance Extracellular vesicles as a platform for 'liquid biopsy' in glioblastoma patients Molecular imaging of breast cancer: present and future directions Liquid biopsies: genotyping circulating tumor DNA Genomic profiling of breast cancers Signatures of breast cancer metastasis at a glance The possibility of clinical sequencing in the management of cancer Systemic treatment approaches in her2-negative advanced breast cancer-guidance on the guidelines Organoid development in cancer genome discovery Translating neoadjuvant therapy into survival benefits: one size does not fit all.Predictive biomarkers for triple negative breast cancer treated with platinum-based chemotherapy.Circulating Tumor DNA as Biomarkers for Cancer Detection.Clinical validation of an ultra high-throughput spiral microfluidics for the detection and enrichment of viable circulating tumor cells.BRAF V600E mutations in urine and plasma cell-free DNA from patients with Erdheim-Chester disease Clinical significance of phenotyping and karyotyping of circulating tumor cells in patients with advanced gastric cancer Bone marrow minimal residual disease was an early response marker and a consistent independent predictor of survival after anti-GD2 immunotherapy.Multiplexed detection of serological cancer markers with plasmon-enhanced Raman spectro-immunoassay.Genetic profiling of tumours using both circulating free DNA and circulating tumour cells isolated from the same preserved whole blood sample.Efficient Capture and Isolation of Tumor-Related Circulating Cell-Free DNA from Cancer Patients Using Electroactive Conducting Polymer Nanowire Platforms Heterogeneity and clinical significance of ESR1 mutations in ER-positive metastatic breast cancer patients receiving fulvestrant.Comprehensive mutation profiling by next-generation sequencing of effusion fluids from patients with high-grade serous ovarian carcinoma.Analysis of tumor template from multiple compartments in a blood sample provides complementary access to peripheral tumor biomarkers Pilot studies for personalized cancer medicine: focusing on the patient for treatment selection.Copy number variations in urine cell free DNA as biomarkers in advanced prostate cancer.Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer.Aneuploidy of chromosome 8 in circulating tumor cells correlates with prognosis in patients with advanced gastric cancer.Concordance between genomic alterations assessed by next-generation sequencing in tumor tissue or circulating cell-free DNA.Latest biopsy approach for suspected metastases in patients with breast cancer.Molecular analysis of circulating tumour cells-biology and biomarkers.Tumor heterogeneity in the clinic: is it a real problem?Brain metastasis: new opportunities to tackle therapeutic resistance.The intra-tumor heterogeneity of cell signaling factors in breast cancer: p4E-BP1 and peIF4E are diffusely expressed and are real potential targets.Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle.Clinical management of breast cancer heterogeneity.Evaluation of targeted therapies in advanced breast cancer: the need for large-scale molecular screening and transformative clinical trial designs.Cell-free circulating tumour DNA as a liquid biopsy in breast cancer.

P2860

Q26750899-9BC8813A-038C-44F7-88C7-082F81DB143F Q26772199-5983E525-6ACB-43D4-9AF3-B5D1ED4BCB4F Q26772870-6766CA72-626E-43D7-BD46-86A560E824B7 Q26777395-F98D63BB-D341-40D1-9B79-A33AAEA29682 Q26778761-883FC78A-6009-4A8E-B485-50185526FDF4 Q26861832-2511EDEA-B433-4552-9BE3-A17E7FFCD922 Q26999488-6719062E-32CD-452E-A39C-70AC970FA95B Q27010159-D8B4CE59-C126-4C9A-A00F-7DC4A12E5C56 Q27013013-95E545A4-FFAC-4549-A211-67EF1EAF329C Q28071451-FA2A3CAB-F4D6-4B9C-A756-0768FCF28084 Q28072144-24069BFC-538C-4F74-9F00-131B4A23F68D Q28080469-393070CE-4FA6-494E-8F6D-2C73246A7B33 Q28083032-DCC22BA7-59A7-4216-B991-A53C6FED98D2 Q30251738-6AC25EB3-2839-4A78-8DB9-A0FE7B701965 Q33441772-1F8003E0-04C0-48B2-8226-33EEC181D632 Q33632125-0FE9CEA2-C30A-415A-A50A-38984E56266F Q33856619-290C4058-7597-4C18-A4DA-96D45C27BD57 Q33976971-19E62459-F90E-4BB0-BE16-4F2A3E04F609 Q34334315-01B1B677-50DA-4C4C-92CE-616E62B1ADB4 Q35102499-BDADE23E-FAFD-45E2-971B-E74857495003 Q35787480-00E41B54-5FDB-4770-BA34-1EF33EDB52EA Q36807241-4D24CB5C-7A0B-47C9-BBD9-6D39DE9AE0FF Q36882961-393D36B5-D70D-435E-A60B-DF3B0A1D19A0 Q36907216-A6E4A78E-E019-4ED3-88B5-4F7E918ED8B0 Q37193365-048C656D-D02C-4359-9A51-4F1BF1A5C5DF Q37295773-261746AE-696E-4CE8-B150-7856CB3A4B38 Q37301452-78B47AF8-D3CD-4817-BC6A-E772B414E5DA Q37392579-5B65F0C8-56EB-4049-AE46-6BB00DCC569A Q37533025-958408EE-D775-4E4A-B24E-6B53E2F2263B Q37592228-54644741-C395-47E7-8CA4-3834EB45ECD5 Q37662237-67DAAAE6-927B-4FCD-AF52-6D9FAAC3297B Q38154494-EB22A811-11EF-446A-B32C-9C5018FEA111 Q38180320-CD6B51F9-A772-41D6-B0EA-FCCC78B84F2D Q38192631-DAFBB076-0D5B-43F8-BC9B-DDFB799E417E Q38222247-43A486A2-E48E-4B39-B24A-F10200F2DBCD Q38233765-6E17245F-86ED-4B2C-B7C8-FD9251A0F3FB Q38390966-CC5A5E22-76A1-4BD1-80FC-85574772EB93 Q38431284-66A5E869-265B-42DB-BB29-CC4F3085C0B5 Q38539671-C83E36C9-C436-4F50-A0B1-595723DF19B7 Q38699764-8FBE9E0E-AF1F-4BFC-943F-CE9CB84D4C10

P2860

Circulating tumour cells and cell-free DNA as tools for managing breast cancer.

http://www.wikidata.org/entity/Q38109808

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Circulating tumour cells and cell-free DNA as tools for managing breast cancer.

@en

type

label

Circulating tumour cells and cell-free DNA as tools for managing breast cancer.

@en

prefLabel

Circulating tumour cells and cell-free DNA as tools for managing breast cancer.

@en

P1433

Q38109808-7E0E074B-CD0F-4D67-8EFC-DDC9B5ECACB6

P1476

Q38109808-D29CB5EB-F89D-44A2-A3B1-6EEDDD5C98E2

P2093

Q38109808-49096EAE-AA7C-45EB-9F73-3C6B5C71409F

Q38109808-7DA6F3D0-2166-4758-9E61-C28B750BA9B8

Q38109808-9E8BFE47-60B5-4F1E-AA1F-EB7CAC411EBD

Q38109808-B0937B06-C04F-44B4-BEA5-124093CEC146

P2860

Q38109808-03991FC3-2A13-4377-927C-E9ADA3C56347

Q38109808-0AD9FCE9-6DF5-4792-AC15-A778C9C56212

Q38109808-0CE5CABF-7EAA-4DBA-A04E-9795554846CE

Q38109808-0D6CE200-5279-4BE5-B15D-C4F6EC8B7B36

Q38109808-0F842F89-8BD8-4C11-85B7-6956BD1DEAB2

Q38109808-13A6610C-B737-427E-8A07-DCDB1195A55A

Q38109808-16428131-ADF6-4291-8C22-82807DE7ACE1

Q38109808-17E6704A-8D04-4064-9850-19E88F9C4582

Q38109808-197B77CF-2A18-452F-9A99-9669DB3C5732

Q38109808-19BC9077-4A24-4125-9570-48A06AF524C5

P2888

Q38109808-CC3B1B74-32B6-488A-8A9B-747DE2D8E0B7

P304

Q38109808-C7B5277A-3012-4057-A3CA-BF59B7955C3B

P31

Q38109808-863302D0-CC6A-445F-975F-6B48F21CFDBB

P356

Q38109808-BB37D3F5-DC99-4D95-B0A2-B49CD33EFDB1

P407

Q38109808-D32C179A-289F-41BD-A689-5611EB094224

P433

Q38109808-9E94D043-49EC-4C1B-8493-E6F662496B28

P478

Q38109808-92A12B77-E1D4-4CD9-BEB1-95C127B16313

P50

Q38109808-2E7E977E-3BF8-4D3D-82E6-739362433E2F

Q38109808-54981414-4B1F-4591-8B5A-5C4B13616EAE

Q38109808-BA4CE6A5-585E-4CCE-8212-DE41FB06019D

Q38109808-CCB7C419-7D73-430E-94BD-D13EADEA2E74

P577

Q38109808-30EE79DB-EE33-49CC-B263-B1235BB12BF5

P6179

Q38109808-D62726A8-B178-4DB2-8A2F-86100B55EE1F

P698

Q38109808-2C872255-5D2D-4396-B4CB-50ADE9906EE3

P356

NRCLINONC.2013.80

P1433

Nature Reviews Clinical Oncology

P1476

Circulating tumour cells and cell-free DNA as tools for managing breast cancer.

@en

P2093

Ana Vivancos

http://www.w3.org/2001/XMLSchema#string

Javier Cortes

http://www.w3.org/2001/XMLSchema#string

Leticia De Mattos-Arruda

http://www.w3.org/2001/XMLSchema#string

Libero Santarpia

http://www.w3.org/2001/XMLSchema#string

P2860

HER-2 gene amplification can be acquired as breast cancer progresses

Comprehensive molecular portraits of human breast tumours

Circulating tumor cells: approaches to isolation and characterization

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

Phosphatidylinositol 3-kinase and antiestrogen resistance in breast cancer

PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients.

A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer.

NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations.

Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer.

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

P2888

nrclinonc.2013.80

P304

377-389

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRCLINONC.2013.80

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Jorge Reis-Filho

Josep Tabernero

Leticia De Mattos-Arruda

P577

2013-05-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1035963907

http://www.w3.org/2001/XMLSchema#string

P698

23712187

http://www.w3.org/2001/XMLSchema#string